Pfizer Inc
PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Nov 3, 2026Score 11/3056% above fair value
$30.67+0.15 (+0.49%)
Close on Nov 2, 2026Market cap $174.81BP/E 40.4Yield 5.61%
Pfizer International Commercial Division Revenues [legacy by Year
International Commercial Division Revenues [legacy 2024–2025 structure] ($M) ($M)
Pfizer International Commercial Division Revenues [legacy: $24,491M in FY2025, up 1.8% from a year earlier.
Latest, FY2025
24,491
Period ended Dec 31, 2025
Change on a year earlier
+1.8%
24,068 in FY2024
History
4 years
Since FY2022
Sources
2
Documents cited below
Where the FY2025 figure comes from
Source: Form 10-K (filed 2026-02-26) ↗
Reported in Form 10-K Segment Note.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | International Commercial Division Revenues [legacy 2024–2025 structure] ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 24,491 | +1.8% | Form 10-K (filed 2026-02-26) ↗ |
| FY2024 | Dec 31, 2024 | 24,068 | -21.1% | Form 10-K (filed 2026-02-26) ↗ |
| FY2023 | Dec 31, 2023 | 30,488 | -46.4% | Form 10-K (filed 2026-02-26) ↗ |
| FY2022 | Dec 31, 2022 | 56,905 | – | Form 10-K (filed 2025-02-27) ↗ |
Cite this data
StockData. (2026). Pfizer International Commercial Division Revenues [legacy ($M), annual FY2022–FY2025 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/div-leg-intl-comm
See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.